Antibodies raised €446k in a Pre-Seed round in Jul 2019. The company is based in London, UK. Investors in the round: Nidobirds Ventures. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
